Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine vs. standard-dose intramuscular vaccine in HIV-1-infected adults

Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina

(2011) Peter Eizenberg et al.   ADVANCES IN THERAPY

Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults

(2011) Curtis Cooper et al.   PLoS One

Response to 2009 Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Patients and the Influence of Prior Seasonal Influenza Vaccination

(2011) Darius Soonawala et al.   PLoS One

Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects

(2011) Naoki Yanagisawa et al.   VACCINE

Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy

(2011) Elena Pariani et al.   VACCINE

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

(2011) Robert W. Frenck et al.   VACCINE

Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients

(2010) O. Manuel et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine in an Immunocompromised Population: A Prospective Study Comparing HIV-Infected Adults with HIV-Uninfected Adults

(2010) N. F. Crum-Cianflone et al.   CLINICAL INFECTIOUS DISEASES

Immune Response after Two Doses of the Novel Split Virion, Adjuvanted Pandemic H1N1 Influenza A Vaccine in HIV-1-Infected Patients

(2010) M. Bickel et al.   CLINICAL INFECTIOUS DISEASES

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials

(2010) Camille Reygrobellet et al.   Human vaccines & immunotherapeutics

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial

(2010) Robert Arnou et al.   Human vaccines & immunotherapeutics

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

(2009) Jiri Beran et al.   BMC Medicine

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

(2009) Ken M Kunisaki et al.   LANCET INFECTIOUS DISEASES

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults

(2008) Isabel Leroux-Roels et al.   VACCINE